|
histone H3K9 methyltransferase activity
|
GO_0046974 |
[Catalysis of the reaction: S-adenosyl-L-methionine + histone H3 L-lysine (position 9) = S-adenosyl-L-homocysteine + histone H3 N6-methyl-L-lysine (position 9). This reaction is the addition of up to three methyl groups to the lysine residue at position 9 of the histone H3 protein.] |
|
obsolete histone lysine N-methyltransferase activity (H3-K24 specific)
|
GO_0046973 |
[OBSOLETE. Catalysis of the addition of a methyl group onto lysine at position 24 of the histone H3 protein.] |
|
Myc-Max complex
|
GO_0071943 |
[A transcription factor complex that consists of a heterodimer of the bHLH-ZIP proteins Myc and Max.] |
|
histone H3K27 methyltransferase activity
|
GO_0046976 |
[Catalysis of the reaction: S-adenosyl-L-methionine + histone H3 L-lysine (position 27) = S-adenosyl-L-homocysteine + histone H3 N6-methyl-L-lysine (position 27). This reaction is the addition of a methyl group to the lysine residue at position 27 of the histone H3 protein.] |
|
XPC complex
|
GO_0071942 |
[A nucleotide-excision repair complex that is involved in damage sensing during global genome nucleotide excision repair (GG-NER). It is part of the pre-incision (or initial recognition) complex bound to sites of DNA damage. In human, it is composed of XPC, RAD23B and CETN2.] |
|
histone H3K36 methyltransferase activity
|
GO_0046975 |
[Catalysis of the reaction: S-adenosyl-L-methionine + histone H3 L-lysine (position 36) = S-adenosyl-L-homocysteine + histone H3 N6-methyl-L-lysine (position 36). This reaction is the addition of a methyl group to the lysine residue at position 36 of the histone H3 protein.] |
|
regulation of bacterial-type flagellum-dependent cell motility by regulation of motor speed
|
GO_0071945 |
[A process that modulates flagellum-dependent motility in bacteria by modulating the speed or direction of rotation of a rotary flagellar motor, mediated by interactions between the braking protein.] |
|
positive regulation of activin secretion
|
GO_0032337 |
[Any process that activates or increases the frequency, rate or extent of the regulated release of activin from a cell.] |
|
cell periphery
|
GO_0071944 |
[The broad region around and including the plasma membrane of a cell, encompassing the cell cortex (inside the cell), the plasma membrane, and any external encapsulating structures.] |
|
negative regulation of activin secretion
|
GO_0032336 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of activin from a cell.] |
|
protein deubiquitination involved in ubiquitin-dependent protein catabolic process
|
GO_0071947 |
[The removal of one or more ubiquitin groups from a protein as part of a process of ubiquitin-dependent protein catabolism.] |
|
negative regulation of inhibin secretion
|
GO_0032339 |
[Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of inhibin from a cell.] |
|
regulation of inhibin secretion
|
GO_0032338 |
[Any process that modulates the frequency, rate or extent of the regulated release of inhibin from a cell.] |
|
cis-acting DNA replication termination
|
GO_0071946 |
[A DNA replication termination process that is initiated by protein binding to a binding site on the same chromosome, but remote from the termination site, via DNA looping or chromosome kissing.] |
|
site-specific DNA replication termination
|
GO_0071170 |
[A DNA replication termination process that takes place at a specific termination site.] |
|
thiamine import across plasma membrane
|
GO_0140125 |
[The directed movement of thiamine from outside of a cell, across the plasma membrane and into the cytosol.] |
|
FAD binding
|
GO_0071949 |
[Binding to the oxidized form, FAD, of flavin-adenine dinucleotide, the coenzyme or the prosthetic group of various flavoprotein oxidoreductase enzymes.] |
|
activation-induced B cell apoptotic process
|
GO_0071948 |
[B cell apoptotic process that occurs upon engagement of either the B cell receptor or CD40. Engagement of either receptor, but not both, leads to expression of fas or related receptors that make the B cell susceptible to fas-ligand mediated death.] |
|
specification of segmental identity, maxillary segment
|
GO_0007382 |
[The specification of the characteristic structures of the maxillary segment following establishment of segment boundaries. Identity is considered to be the aggregate of characteristics by which a structure is recognized.] |
|
specification of segmental identity, labial segment
|
GO_0007381 |
[The specification of the characteristic structures of the labial segment following establishment of segment boundaries. Identity is considered to be the aggregate of characteristics by which a structure is recognized.] |